Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera

Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera
Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0